Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010:2010:906082.
doi: 10.1155/2010/906082. Epub 2009 Dec 6.

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS

Muriel De Bock  1 , Dominique de Seny, Marie-Alice Meuwis, Jean-Paul Chapelle, Edouard Louis, Michel Malaise, Marie-Paule Merville, Marianne Fillet
Affiliations
Review

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS

Muriel De Bock et al. J Biomed Biotechnol. 2010.

Abstract

Protein profiling using SELDI-TOF-MS has gained over the past few years an increasing interest in the field of biomarker discovery. The technology presents great potential if some parameters, such as sample handling, SELDI settings, and data analysis, are strictly controlled. Practical considerations to set up a robust and sensitive strategy for biomarker discovery are presented. This paper also reviews biological fluids generally available including a description of their peculiar properties and the preanalytical challenges inherent to sample collection and storage. Finally, some new insights for biomarker identification and validation challenges are provided.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of different ProteinChip array surfaces and wash conditions. The combination of ProteinChip array surface types and wash conditions maximize the potential for protein biomarker discovery.
Figure 2
Figure 2
Experimental variables that can affect proteomics data. Most of the steps shown are involved in all proteomics workflows, but SELDI technology performs many of them on a single platform.
Figure 3
Figure 3
Protein mass spectra collected on CM10 and IMAC-Cu2+ ProteinChip arrays with serum samples provided by five patients with arthritidies (including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis) and five noninflammatory controls (NIC) (including osteoarthritis). (a) The inflammatory-related proteins S100A8, S100A12, S100A9, and one of its variant S100A9* are arthritis biomarkers detected on CM10 arrays. (b) On IMAC-Cu2+ ProteinChip arrays, SAA and its 2 variants (SAA-R and SAA-RS) are illustrated, reproduced from [19].
Figure 4
Figure 4
Modified transthyretin forms observed in ovarian cancer sample, adapted from [123].
See this image and copyright information in PMC

References

    1. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature. 2003;425(6961):p. 905. - PubMed
    1. Westont AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. Journal of Proteome Research. 2004;3(2):179–196. - PubMed
    1. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004;4(12):3665–3685. - PubMed
    1. Mitulovic G, Stingl C, Smoluch M, et al. Automated, on-line two-dimensional nano liquid chromatography tandem mass spectrometry for rapid analysis of complex protein digests. Proteomics. 2004;4(9):2545–2557. - PubMed
    1. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Molecular & Cellular Proteomics. 2003;2(10):1096–1103. - PubMed

MeSH terms